How much is Xcell Biosciences worth in 2026?

Xcell Biosciences has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has Xcell Biosciences raised?

Xcell Biosciences has raised $60.4M in total funding across 1 funding rounds.

Xcell Biosciences

Discovery Tools (Healthcare)Website

Xcell Biosciences valuation and funding history | Last updated: December 17, 2024 | 1 funding rounds

Current Valuation

N/A

As of December 17, 2024

Total Funding Raised

$60.4M

Across 1 round

Last Round

Later Stage VC

$27.5M

Last Funding

Dec 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
December 17, 2024	Later Stage VC	$27.5M	N/A	-

Valuation Analysis

Current Valuation Metrics

Xcell Biosciences is currently valued at N/A as of December 17, 2024. The company has raised a total of $60.4M in funding across 1 funding round.

Track Xcell Biosciences Valuation Updates

Get notified when Xcell Biosciences raises new funding or valuation changes

Explore More Data

Detailed analysis for Xcell Biosciences

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Xcell Biosciences's valuation history, funding rounds, and growth metrics.

No credit card required

What is Xcell Biosciences Worth in 2026?

Xcell Biosciences is a leading private company in the Discovery Tools (Healthcare) sector. Track Xcell Biosciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Xcell Biosciences Valuation is Determined

Private company valuations like Xcell Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.